Advisory Alpha’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $757K | Buy |
1,701
+187
| +12% | +$83.3K | 0.02% | 205 |
|
|
2025
Q1 | $734K | Buy |
1,514
+222
| +17% | +$108K | 0.03% | 193 |
|
|
2024
Q4 | $520K | Buy |
1,292
+117
| +10% | +$47.1K | 0.02% | 228 |
|
|
2024
Q3 | $546K | Buy |
1,175
+188
| +19% | +$87.4K | 0.02% | 221 |
|
|
2024
Q2 | $463K | Buy |
987
+136
| +16% | +$63.7K | 0.02% | 222 |
|
|
2024
Q1 | $356K | Buy |
+851
| New | +$356K | 0.01% | 265 |
|
|
2020
Q4 | – | Sell |
-67
| Closed | -$18K | – | 631 |
|
|
2020
Q3 | $18K | Buy |
+67
| New | +$18K | ﹤0.01% | 344 |
|
|
2020
Q2 | – | Sell |
-170
| Closed | -$45.5K | – | 603 |
|
|
2020
Q1 | $45.5K | Hold |
170
| – | – | 0.01% | 217 |
|
|
2019
Q4 | $38.5K | Buy |
170
+89
| +110% | +$20.2K | 0.01% | 311 |
|
|
2019
Q3 | $13.7K | Buy |
+81
| New | +$13.7K | ﹤0.01% | 416 |
|
|
2019
Q2 | – | Sell |
-19
| Closed | -$3.23K | – | 629 |
|
|
2019
Q1 | $3.23K | Buy |
+19
| New | +$3.23K | ﹤0.01% | 513 |
|